Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Trends Pharmacol Sci 45:503519
In the phase 2 obesity and diabetes trials, more participants receiving retatrutide reported nausea compared with those in the placebo group
MoradiMMojtahedzadehMMandegariASoltan-SharifiMSNajafiAKhajaviMRet alThe role of glutathione-S-transferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine
GLP-1 inhibitors are injectable medications originally developed to treat type 2 diabetes
Baseline and follow-up potassium levels are essential for safe combination therapy
Eli Lillys TRIUMPH trial program for retatrutide includes multiple Phase 3 studies
US$ 22.64
US$ 27.78
US$ 20.18
US$ 26.86
US$ 23.70
US$ 24.29
US$ 27.42
US$ 24.06
US$ 26.04
US$ 25.61
US$ 24.80
US$ 28.33
US$ 20.93
US$ 23.87
US$ 21.29
US$ 24.37
